Literature DB >> 16553809

The role of gamma interferon in acquired host resistance against Staphylococcus aureus infection in mice.

Sanae Sasaki1, Yoh-Ichi Tagawa, Yoichiro Iwakura, Akio Nakane.   

Abstract

We investigated the expression of an acquired host resistance against Staphylococcus aureus infection in mice. When C57BL/6 mice were immunized with viable S. aureus and challenged with S. aureus eight weeks later, the elimination of S. aureus from the spleen and liver was enhanced in the immunized mice compared with the nonimmunized mice. When gamma interferon (IFN-gamma(-/-)) mice were immunized and challenged, the bacterial numbers in the organs of immunized mice were comparable to those in the nonimmunized mice, suggesting that IFN-gamma plays a critical role in an acquired host resistance against S. aureus infection. IFN-gamma(-/-) mice produced the lower level of anti-S. aureus immunoglobulin M (IgM) and IgG2a antibodies compared with C57BL/6 mice. To elucidate the role of IFN-gamma produced during a challenge with S. aureus, a single injection of anti-IFN-gamma monoclonal antibody to mice was carried out 1 h before challenge. An acquired resistance against S. aureus infection was inhibited by injecting with anti-IFN-gamma monoclonal antibody. However, anti-IFN-gamma monoclonal antibody treatment failed to modulate anti-S. aureus IgM, IgG1 or IgG2a responses in these animals. These results demonstrated that IFN-gamma is required for an acquired resistance against S. aureus infection in mice. However, IFN-gamma induced during the challenge failed to affect the secondary antibody responses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16553809     DOI: 10.1111/j.1574-695X.2005.00037.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  10 in total

1.  O-Acetylation of Peptidoglycan Limits Helper T Cell Priming and Permits Staphylococcus aureus Reinfection.

Authors:  Marisel Sanchez; Stacey L Kolar; Sabrina Müller; Christopher N Reyes; Andrea J Wolf; Chihiro Ogawa; Rajat Singhania; Daniel D De Carvalho; Moshe Arditi; David M Underhill; Gislâine A Martins; George Y Liu
Journal:  Cell Host Microbe       Date:  2017-09-21       Impact factor: 21.023

2.  Collaborative Interferon-γ and Interleukin-17 Signaling Protects the Oral Mucosa from Staphylococcus aureus.

Authors:  Jobert G Barin; Monica V Talor; Julie A Schaub; Nicola L Diny; Xuezhou Hou; Matthew Hoyer; Nathan K Archer; Elizabeth S Gebremariam; Meghan F Davis; Lloyd S Miller; Noel R Rose; Daniela Čiháková
Journal:  Am J Pathol       Date:  2016-07-26       Impact factor: 4.307

3.  Gamma interferon confers resistance to infection with Staphylococcus aureus in human vascular endothelial cells by cooperative proinflammatory and enhanced intrinsic antibacterial activities.

Authors:  Henry Beekhuizen; Joke S van de Gevel
Journal:  Infect Immun       Date:  2007-09-24       Impact factor: 3.441

4.  The antifungal vaccine derived from the recombinant N terminus of Als3p protects mice against the bacterium Staphylococcus aureus.

Authors:  Brad Spellberg; Ashraf S Ibrahim; Michael R Yeaman; Lin Lin; Yue Fu; Valentina Avanesian; Arnold S Bayer; Scott G Filler; Peter Lipke; Henry Otoo; John E Edwards
Journal:  Infect Immun       Date:  2008-07-21       Impact factor: 3.441

5.  Individual variation is the key to the development of a vaccine against Staphylococcus aureus: a comparative study between mice lineages.

Authors:  D P Dos Santos; I P R Muniz; A F Queiroz; I S Pereira; M P A Souza; L J Lima; L R O Sousa; I S Ribeiro; M P L Galantini; L M Marques; T B Figueiredo; R A A da Silva
Journal:  Braz J Med Biol Res       Date:  2018-03-26       Impact factor: 2.590

6.  Two Vaccines for Staphylococcus aureus Induce a B-Cell-Mediated Immune Response.

Authors:  Christopher D Dupont; Ingrid L Scully; Ross M Zimnisky; Brinda Monian; Christina P Rossitto; Ellen B O'Connell; Kathrin U Jansen; Annaliesa S Anderson; J Christopher Love
Journal:  mSphere       Date:  2018-08-22       Impact factor: 4.389

7.  Immunization protected well nourished mice but not undernourished ones from lung injury in Methicillin-resistant Staphylococcus aureus (MRSA) infection.

Authors:  Thais Graziela Donegá França; Larissa Lumi Watanabe Ishikawa; Sofia Fernanda Gonçalves Zorzella-Pezavento; Fernanda Chiuso-Minicucci; Clara Pires Fujiara Guerino; Maria de Lourdes Ribeiro de Souza da Cunha; Alexandrina Sartori
Journal:  BMC Microbiol       Date:  2009-11-23       Impact factor: 3.605

8.  MRSA Infections in HIV-Infected People Are Associated with Decreased MRSA-Specific Th1 Immunity.

Authors:  Netanya S Utay; Annelys Roque; J Katherina Timmer; David R Morcock; Claire DeLeage; Anoma Somasunderam; Amy C Weintrob; Brian K Agan; Jacob D Estes; Nancy F Crum-Cianflone; Daniel C Douek
Journal:  PLoS Pathog       Date:  2016-04-19       Impact factor: 6.823

9.  The Antioxidant Polysaccharide from Semiaquilegia adoxoides (DC.) Makino Adjusts the Immune Response of Mice Infected by Bacteria.

Authors:  Yunqiao Yang; Lei Guo; Kinza Tariq; Weiyu Zhang; Chong Li; Fareed Qamar Memon; Beibei Chai; Zheng Li; Junying Sun; Yunru Chen; Geyin Zhang; Qinmei Li; Shuaiyang Wang; Lizhen Wang; Chongbo Lai; Mingsheng Jiang; Hongbin Si
Journal:  Evid Based Complement Alternat Med       Date:  2020-02-19       Impact factor: 2.629

10.  Functional and Transcriptional Adaptations of Blood Monocytes Recruited to the Cystic Fibrosis Airway Microenvironment In Vitro.

Authors:  Bijean D Ford; Diego Moncada Giraldo; Camilla Margaroli; Vincent D Giacalone; Milton R Brown; Limin Peng; Rabindra Tirouvanziam
Journal:  Int J Mol Sci       Date:  2021-03-03       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.